A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairs
about
Incidental Findings with Genomic Testing: Implications for Genetic Counseling PracticeStakeholders' perspectives on biobank-based genomic research: systematic review of the literatureStakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs)Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.'Information is information': a public perspective on incidental findings in clinical and research genome-based testingCompare and contrast: a cross-national study across UK, USA and Greek experts regarding return of incidental findings from clinical sequencingEthical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research.Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.Incidental findings from clinical sequencing in Greece: reporting experts' attitudes.Public's Views toward Return of Secondary Results in Genomic Sequencing: It's (Almost) All about the Choice.Views of primary care providers regarding the return of genome sequencing incidental findings.Prenatal whole exome sequencing: the views of clinicians, scientists, genetic counsellors and patient representatives."Not pathogenic until proven otherwise": perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project.
P2860
Q26777211-42505EF8-EC5D-4C95-AEFA-BC4A63E39A57Q27007817-2101C912-0D98-4FF1-AD2D-07B19C8941C9Q33737044-D1013DB4-A0CD-405B-98DD-CFDE1E9B5E8EQ33865515-E70A8FDC-EA89-4FC8-B670-01FBBF2F7BC2Q33902567-F9E822EB-5FBF-4F6E-A20B-BEE281D4D697Q35101415-6B71171F-38FF-4804-82A5-B2FD598F63B0Q36585040-526AD24E-CC44-4981-BED6-D348C3F77E05Q36590467-F723BEE6-E0E2-4C68-9E11-A4EAC2DD93F7Q36868046-D835305B-5839-4388-9286-F5B01BCF9B8AQ42076817-0566C72D-5A56-4EBF-832A-E053F5331021Q47810737-D27D689B-15D8-4778-91FF-BAC89894ED2BQ48081855-5C858357-F3C8-495F-B11A-D1E1F793BB8FQ53030293-BFF6D5BD-D030-4B04-A909-B8B801A3B450Q55112941-C6BC5969-38D1-4844-A2DA-0189D7092AC6
P2860
A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairs
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A closer look at the recommend ...... titutional review board chairs
@en
type
label
A closer look at the recommend ...... titutional review board chairs
@en
prefLabel
A closer look at the recommend ...... titutional review board chairs
@en
P2093
P2860
P50
P1476
A closer look at the recommend ...... titutional review board chairs
@en
P2093
Christian M Simon
Debra S Brandt
Laura Shinkunas
Martha Driessnack
Megan F Liu
Nancy R Downing
P2860
P304
P356
10.1007/S10897-013-9583-5
P577
2013-04-02T00:00:00Z